Resultados de la búsqueda 331-340 of 14374 for Ovary

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients ...

  2. Obstetricia y Ginecología - Ensayos clínicos

    The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...

  4. Ensayos clínicos - Neurología

    The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in ...

  5. Ensayos clínicos - Neurología

    The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in ...

  6. Cirugía pediátrica - Ensayos clínicos

    The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients ...

  7. Ensayos clínicos - Neurología

    The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in ...

  8. Oncología (médica) - Ensayos clínicos

    Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.